Pangea Natural Foods files amended financials, MD&A

Executive Summary

• Pangea Natural Foods Inc. has filed amended and restated interim financial statements and Management’s Discussion and Analysis (MD&A) for the six-month period ended April 30, 2025, and the nine-month period ended July 31, 2025.
• The filing was made in response to a continuous disclosure review by the British Columbia Securities Commission (BCSC).
• The amendments specifically address the accounting policy choice regarding the acquisition of Amino Innovations Inc. and the impairment indicator assessment of intangible assets and goodwill as of July 31, 2025.

Key Details

• Filing Type: Amended and Restated Interim Financial Statements and MD&A.
• Reporting Periods Covered:
  • Six-month period ended April 30, 2025.
  • Nine-month period ended July 31, 2025.
• Reason for Filing: Continuous disclosure review by the British Columbia Securities Commission.
• Specific Disclosures Added:
  • Accounting policy choice relating to the acquisition of Amino Innovations Inc. (acquired April 9, 2025).
  • Impairment indicator assessment of the company's intangible asset and goodwill as of July 31, 2025.
• Filing Location: Filed under the company's issuer profile on SEDAR+.

Notable Quotes

• None provided in the text.